Finding the best prices at pharmacies near you...

Skin Cancer

Skin Cancer

Skin cancer arises due to the development of abnormal skin cells, which occurs because of mutations in the DNA. It is the most common form of cancer in the United States and is usually caused by exposure of the skin to the sun or other sources of ultraviolet radiation (such as tanning beds).

There are three main varieties of skin cancer: basal-cell cancer, squamous-cell skin cancer, and melanoma. It typically first appears in areas of sun-exposed skin, such as the scalp, face, lips, ears, neck chest and hands, but it may appear anywhere on the body.

Symptoms depend on the form of skin cancer, but common signs of the condition include irregular moles, bumps on the skin with visible blood vessels, scaly skin, and lesions on the skin. Among the factors that may increase the likelihood of skin cancer are a history of sunburns, fair skin, moles, family history of skin cancer, a weakened immune system, exposure to radiation, and exposure to certain toxic chemicals or substances.

Treatment of skin cancer may involve surgery, chemotherapy, radiation therapy and medication. Drug classes commonly used to treat the conditions include pyrimidine analogs, other antimetabolites antineoplastic agents, topical antivirals, other specific antirheumatics, other antineoplastic agents, taxanes, antineoplastic monoclonal antibodies, and other topical antineoplastics.

Drugs Used To Treat Skin Cancer:



Drugs related to Skin Cancer:

Blog Posts Related to Skin Cancer:


Cancer can present itself in many ways and has varying and debilitating symptoms. However, some forms of cancer are chronic and could pose more challenges regarding health care management. Cancer is a serious condition with various causes, and different types of cancer affect people differently....

Read More... Jan 06, 2023

Americans have been urged to take precautions to protect against ultraviolet (UV) radiation and skin cancer during the hotter months of the year. In a statement issued by the US Food and Drug Administration (FDA), FDA Commissioner Scott Gottlieb, MD, highlighted the dangers and prevalence of skin...

Read More... Jun 15, 2018

The US Food & Drug Administration's (FDA) decision to approve a medication to treat patients whose cancer has a specific genetic feature, or biomarker, has been hailed as an "important first" in the fight against the disease. Keytruda (pembrolizumab) is a monoclonal antibody already in use to...

Read More... May 24, 2017